vs

Side-by-side financial comparison of HAWKINS INC (HWKN) and Zai Lab Ltd (ZLAB). Click either name above to swap in a different company.

HAWKINS INC is the larger business by last-quarter revenue ($244.1M vs $127.1M, roughly 1.9× Zai Lab Ltd). On growth, Zai Lab Ltd posted the faster year-over-year revenue change (17.1% vs 7.9%). HAWKINS INC produced more free cash flow last quarter ($21.2M vs $-26.7M). Over the past eight quarters, Zai Lab Ltd's revenue compounded faster (20.8% CAGR vs 8.2%).

Hawkins Cookers Limited Inc and formerly known as Pressure Cookers and Appliances Ltd, is an Indian company which manufactures pressure cookers and cookware. The company is based in Mumbai and has three manufacturing plants at Thane, Hoshiarpur and Jaunpur. It manufactures under brand names of Hawkins, Futura, Contura, Hevibase, Big Boy, Miss Mary and Ventura. Hawkins is one of the largest pressure cooker manufacturers in India and exports its products to more than 65 countries.

Zai Lab Ltd is a global biopharmaceutical company focused on developing, manufacturing and commercializing innovative therapies for oncology, autoimmune disorders, infectious diseases and other unmet medical needs. It operates primarily in the Greater China region and partners with leading global biotech firms to expand access to life-saving treatments for underserved patient populations.

HWKN vs ZLAB — Head-to-Head

Bigger by revenue
HWKN
HWKN
1.9× larger
HWKN
$244.1M
$127.1M
ZLAB
Growing faster (revenue YoY)
ZLAB
ZLAB
+9.2% gap
ZLAB
17.1%
7.9%
HWKN
More free cash flow
HWKN
HWKN
$47.9M more FCF
HWKN
$21.2M
$-26.7M
ZLAB
Faster 2-yr revenue CAGR
ZLAB
ZLAB
Annualised
ZLAB
20.8%
8.2%
HWKN

Income Statement — Q3 FY2026 vs Q4 FY2025

Metric
HWKN
HWKN
ZLAB
ZLAB
Revenue
$244.1M
$127.1M
Net Profit
$14.3M
Gross Margin
20.8%
51.0%
Operating Margin
9.2%
-54.6%
Net Margin
5.9%
Revenue YoY
7.9%
17.1%
Net Profit YoY
-4.7%
EPS (diluted)
$0.69
$-0.05

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
HWKN
HWKN
ZLAB
ZLAB
Q4 25
$244.1M
$127.1M
Q3 25
$280.4M
$115.4M
Q2 25
$293.3M
$109.1M
Q1 25
$245.3M
$105.7M
Q4 24
$226.2M
$108.5M
Q3 24
$247.0M
$101.8M
Q2 24
$255.9M
$100.1M
Q1 24
$87.1M
Net Profit
HWKN
HWKN
ZLAB
ZLAB
Q4 25
$14.3M
Q3 25
$22.6M
$-36.0M
Q2 25
$29.2M
$-40.7M
Q1 25
$16.3M
$-48.4M
Q4 24
$15.0M
Q3 24
$24.1M
$-41.7M
Q2 24
$28.9M
$-80.3M
Q1 24
$-53.5M
Gross Margin
HWKN
HWKN
ZLAB
ZLAB
Q4 25
20.8%
51.0%
Q3 25
24.1%
59.5%
Q2 25
24.7%
60.6%
Q1 25
21.3%
63.6%
Q4 24
21.4%
61.5%
Q3 24
24.4%
64.1%
Q2 24
25.3%
64.9%
Q1 24
61.4%
Operating Margin
HWKN
HWKN
ZLAB
ZLAB
Q4 25
9.2%
-54.6%
Q3 25
12.1%
-42.3%
Q2 25
14.1%
-50.3%
Q1 25
10.0%
-53.3%
Q4 24
9.3%
-62.6%
Q3 24
13.7%
-66.6%
Q2 24
15.6%
-76.0%
Q1 24
-80.7%
Net Margin
HWKN
HWKN
ZLAB
ZLAB
Q4 25
5.9%
Q3 25
8.1%
-31.2%
Q2 25
9.9%
-37.3%
Q1 25
6.7%
-45.8%
Q4 24
6.6%
Q3 24
9.8%
-40.9%
Q2 24
11.3%
-80.2%
Q1 24
-61.4%
EPS (diluted)
HWKN
HWKN
ZLAB
ZLAB
Q4 25
$0.69
$-0.05
Q3 25
$1.08
$-0.03
Q2 25
$1.40
$-0.04
Q1 25
$0.77
$-0.04
Q4 24
$0.72
$-0.09
Q3 24
$1.16
$-0.04
Q2 24
$1.38
$-0.08
Q1 24
$-0.05

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
HWKN
HWKN
ZLAB
ZLAB
Cash + ST InvestmentsLiquidity on hand
$689.6M
Total DebtLower is stronger
$264.0M
Stockholders' EquityBook value
$518.9M
$715.5M
Total Assets
$976.5M
$1.2B
Debt / EquityLower = less leverage
0.51×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
HWKN
HWKN
ZLAB
ZLAB
Q4 25
$689.6M
Q3 25
$717.2M
Q2 25
$732.2M
Q1 25
$5.1M
$757.3M
Q4 24
$779.7M
Q3 24
$616.1M
Q2 24
$630.0M
Q1 24
$650.8M
Total Debt
HWKN
HWKN
ZLAB
ZLAB
Q4 25
$264.0M
Q3 25
$279.0M
Q2 25
$299.0M
Q1 25
$149.0M
Q4 24
$114.0M
Q3 24
$104.0M
Q2 24
$134.0M
Q1 24
Stockholders' Equity
HWKN
HWKN
ZLAB
ZLAB
Q4 25
$518.9M
$715.5M
Q3 25
$507.0M
$759.9M
Q2 25
$484.6M
$791.7M
Q1 25
$460.3M
$810.8M
Q4 24
$457.0M
$840.9M
Q3 24
$443.4M
$667.7M
Q2 24
$421.2M
$704.2M
Q1 24
$762.2M
Total Assets
HWKN
HWKN
ZLAB
ZLAB
Q4 25
$976.5M
$1.2B
Q3 25
$984.2M
$1.2B
Q2 25
$988.3M
$1.2B
Q1 25
$769.9M
$1.2B
Q4 24
$707.2M
$1.2B
Q3 24
$689.7M
$985.3M
Q2 24
$702.7M
$987.4M
Q1 24
$988.4M
Debt / Equity
HWKN
HWKN
ZLAB
ZLAB
Q4 25
0.51×
Q3 25
0.55×
Q2 25
0.62×
Q1 25
0.32×
Q4 24
0.25×
Q3 24
0.23×
Q2 24
0.32×
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
HWKN
HWKN
ZLAB
ZLAB
Operating Cash FlowLast quarter
$35.6M
$-26.0M
Free Cash FlowOCF − Capex
$21.2M
$-26.7M
FCF MarginFCF / Revenue
8.7%
-21.0%
Capex IntensityCapex / Revenue
5.9%
0.5%
Cash ConversionOCF / Net Profit
2.48×
TTM Free Cash FlowTrailing 4 quarters
$87.7M
$-158.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
HWKN
HWKN
ZLAB
ZLAB
Q4 25
$35.6M
$-26.0M
Q3 25
$39.5M
$-32.0M
Q2 25
$31.5M
$-31.0M
Q1 25
$30.8M
$-61.7M
Q4 24
$21.0M
$-55.8M
Q3 24
$41.6M
$-26.8M
Q2 24
$17.6M
$-42.2M
Q1 24
$-90.1M
Free Cash Flow
HWKN
HWKN
ZLAB
ZLAB
Q4 25
$21.2M
$-26.7M
Q3 25
$28.7M
$-35.0M
Q2 25
$17.9M
$-33.9M
Q1 25
$19.8M
$-63.2M
Q4 24
$12.3M
$-58.4M
Q3 24
$31.0M
$-28.2M
Q2 24
$6.9M
$-42.9M
Q1 24
$-91.1M
FCF Margin
HWKN
HWKN
ZLAB
ZLAB
Q4 25
8.7%
-21.0%
Q3 25
10.2%
-30.4%
Q2 25
6.1%
-31.1%
Q1 25
8.1%
-59.9%
Q4 24
5.4%
-53.8%
Q3 24
12.5%
-27.7%
Q2 24
2.7%
-42.9%
Q1 24
-104.5%
Capex Intensity
HWKN
HWKN
ZLAB
ZLAB
Q4 25
5.9%
0.5%
Q3 25
3.9%
2.6%
Q2 25
4.6%
2.6%
Q1 25
4.5%
1.5%
Q4 24
3.9%
2.4%
Q3 24
4.3%
1.3%
Q2 24
4.2%
0.7%
Q1 24
1.1%
Cash Conversion
HWKN
HWKN
ZLAB
ZLAB
Q4 25
2.48×
Q3 25
1.75×
Q2 25
1.08×
Q1 25
1.89×
Q4 24
1.40×
Q3 24
1.73×
Q2 24
0.61×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

HWKN
HWKN

Manufactured Blended Or Repackaged Products$107.0M44%
Industrial Solutions$53.6M22%
Food$29.2M12%
Nutrition$24.6M10%
Bulk Products$12.0M5%
Water Surplus Inc.$8.4M3%
Pharmaceutical$7.3M3%
Other$1.5M1%

ZLAB
ZLAB

Zejula$56.0M44%
Other$21.9M17%
Nuzyra$16.0M13%
Optune$11.9M9%
XACDURO$10.7M8%
Qinlock$9.7M8%
AUGTYRO$836.0K1%

Related Comparisons